COVID-19 Update | South Africa plans to vaccinate 200,000 people daily against coronavirus: Report
South Africa has been the hardest hit nation on the continent by COVID-19. It has recorded both the highest number of cases in Africa – more than 1.5 million – and of deaths, with more than 50,000 fatalities.
Reuters
March 28, 2021 / 04:29 PM IST
South Africa | In the world’s most unequal country, the disease hit the poor the hardest and the economic downturn sent unemployment to 42 percent. But South Africa had a secret weapon: Health professionals who are veterans of the country’s longstanding battles against HIV/AIDS and drug-resistant TB. The country’s leaders heeded their advice on how to deal with the coronavirus, and though there have been ups and downs, the worst-case scenarios have not yet come to pass. (Image: AP)
South Africa plans to administer coronavirus vaccines to up to 200,000 people a day beginning around May, the Sunday Times newspaper said on Sunday, citing Health Minister Zweli Mkhize.
According to the report, more than 2,000 vaccination sites will be set up. The plan is based on the expected arrival of the first batch of 2.8 million Johnson & Johnson vaccine doses at the end of April, the newspaper said.
The Health Ministry did not respond to telephone calls and text messages from Reuters seeking comment.
Majority want govt to suspend flights from UK, South Africa amid jump in COVID-19 cases: Survey
South Africa has been the hardest hit nation on the continent by COVID-19. It has recorded both the highest number of cases in Africa – more than 1.5 million – and of deaths, with more than 50,000 fatalities.
The vaccination rollout has been slow, with only 231,605 people, mainly frontline health workers, inoculated so far. The government plans to vaccinate 40 million people, or two-thirds of the population.
After pausing the rollout of the AstraZeneca vaccine in February, South Africa started inoculating healthcare workers with Johnson & Johnson shots.
The government previously said it had secured 20 million doses of the two-dose Pfizer-BioNTech vaccine in bilateral negotiations, with deliveries ramping up from the second quarter of the year.